메뉴 건너뛰기




Volumn 41, Issue 5, 2005, Pages 764-765

Moxifloxacin is efficacious for treatment of community-acquired lung abscesses in adults [6]

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CLINDAMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

EID: 23844451045     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/432626     Document Type: Letter
Times cited : (8)

References (10)
  • 1
    • 15744394413 scopus 로고    scopus 로고
    • Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes
    • Wang JL, Chen KY, Fang CT, Hsueh PR, Yang PC, Chang SC. Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes. Clin Infect Dis 2005; 40:915-22.
    • (2005) Clin Infect Dis , vol.40 , pp. 915-922
    • Wang, J.L.1    Chen, K.Y.2    Fang, C.T.3    Hsueh, P.R.4    Yang, P.C.5    Chang, S.C.6
  • 2
    • 15744366144 scopus 로고    scopus 로고
    • The role of anaerobic bacteria in lung abscess
    • Bartlett JG. The role of anaerobic bacteria in lung abscess. Clin Infect Dis 2005; 40:923-5.
    • (2005) Clin Infect Dis , vol.40 , pp. 923-925
    • Bartlett, J.G.1
  • 3
  • 4
    • 0020586512 scopus 로고
    • Clindamycin compared with penicillin for the treatment of anaerobic lung abscess
    • Levison ME, Mangura CT, Lorber B, et al. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med 1983; 98:466-71.
    • (1983) Ann Intern Med , vol.98 , pp. 466-471
    • Levison, M.E.1    Mangura, C.T.2    Lorber, B.3
  • 5
    • 0025665180 scopus 로고
    • Clindamycin vs. penicillin for anaerobic lung infections: High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus
    • Gudiol F, Manressa F, Pallares R, et al. Clindamycin vs. penicillin for anaerobic lung infections: high rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus. Arch Intern Med 1990; 150:2525-9.
    • (1990) Arch Intern Med , vol.150 , pp. 2525-2529
    • Gudiol, F.1    Manressa, F.2    Pallares, R.3
  • 6
    • 0027722596 scopus 로고
    • Monotherapy using amoxicillin/clavulanic acid as treatment of first choice in community-acquired lung abscess: Apropos of 57 cases
    • Germaud P, Poirier J, Jacqueme P, et al. Monotherapy using amoxicillin/clavulanic acid as treatment of first choice in community-acquired lung abscess: apropos of 57 cases. Rev Pneumol Clin 1993; 49:137-41.
    • (1993) Rev Pneumol Clin , vol.49 , pp. 137-141
    • Germaud, P.1    Poirier, J.2    Jacqueme, P.3
  • 7
    • 0037364084 scopus 로고    scopus 로고
    • Efficacy and safety of sequential amoxicillin-clavulanate in the treatment of anaerobic lung infections
    • Fernandez-Sabe N, Carratala J, Dorca J, et al. Efficacy and safety of sequential amoxicillin-clavulanate in the treatment of anaerobic lung infections. Eur J Clin Microbiol Infect Dis 2003; 22:185-7.
    • (2003) Eur J Clin Microbiol Infect Dis , vol.22 , pp. 185-187
    • Fernandez-Sabe, N.1    Carratala, J.2    Dorca, J.3
  • 8
    • 10744225504 scopus 로고    scopus 로고
    • Ampicillin + sulbactam vs clindamycin ± cephalosporin for the treatment of aspiration pneumonia and primary lung abscess
    • Study Group on Aspiration Pneumonia
    • Allewelt M, Schuler P, Bolcskei PL, Mauch H, Lode H. Ampicillin + sulbactam vs clindamycin ± cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Study Group on Aspiration Pneumonia. Clin Microbiol Infect 2004; 10:163-70.
    • (2004) Clin Microbiol Infect , vol.10 , pp. 163-170
    • Allewelt, M.1    Schuler, P.2    Bolcskei, P.L.3    Mauch, H.4    Lode, H.5
  • 9
    • 0035867012 scopus 로고    scopus 로고
    • Clinical perspectives on new antimicrobials: Focus on fluoroquinolones
    • Talan DA. Clinical perspectives on new antimicrobials: focus on fluoroquinolones. Clin Infect Dis 2001; 32(Suppl 1):S64-71.
    • (2001) Clin Infect Dis , vol.32 , Issue.SUPPL. 1
    • Talan, D.A.1
  • 10
    • 0034061875 scopus 로고    scopus 로고
    • Moxifloxacin: A review of its clinical potential in the management of community-acquired respiratory tract infections
    • Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs 2000; 59:115-39.
    • (2000) Drugs , vol.59 , pp. 115-139


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.